Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

John Hyatt (NPI 1184696346)

Field	Value
Entity Type	Individual
Organization	John Hyatt
Address	246 Catalina Dr
City	Ashland
State	OR
ZIP	97520
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	February 2, 2006

Payer Source	Total Paid
Medicare	$1.6M
Medicaid	$0

Key Findings

This provider is functionally single‑payer: lifetime Medicare revenue is $1.6M while Medicaid billing is listed as none, indicating no Medicaid activity on file. That payer concentration will shape contracting and reimbursement risk because the practice depends entirely on Medicare volume and rates.

Revenue concentration is high: the precomputed top 3 Medicare codes account for 84.0% of the provider's total Medicare revenue, with J0178 alone contributing $932.3K (59.6%). Such concentration signals that changes in drug reimbursement or utilization for those specific injections would materially affect overall revenue.

The code mix is consistent with an office‑based retina practice focused on intravitreal biologic therapy and related diagnostics: J0178 (1.4K claims, $685 avg paid/claim, $932.3K revenue), J2777 (9.4K claims, $29 avg paid/claim, $271.5K revenue), and 67028 (1.1K claims, $101 avg paid/claim, $109.8K revenue) together drive the majority of billing. High volume of injection codes plus the presence of OCT (92134) and E/M codes supports a workflow centered on frequent injections, monitoring imaging, and recurrent follow‑up visits.

Competitive standing on primary drug codes is modest to typical: J0178 ranks #930 of 3204 providers nationally (71th percentile) and J2777 ranks #1056 of 2039 providers nationally (48th percentile), both described as typical or unremarkable volumes. By contrast, intravitreal injection procedure 67028 ranks #1283 of 4255 (70th percentile), also in a typical range; collectively these rank positions suggest the provider is an established, steady participant in anti‑VEGF/faricimab delivery but not a national outlier.

Operational intensity appears elevated in office encounters and imaging: 99214 (645 claims, $88 avg paid/claim, $56.8K revenue) ranks #30965 of 479517 providers nationally (94th percentile; notably above typical), 92134 (1.7K claims, $30 avg paid/claim, $51.8K revenue) ranks in the 95th percentile (notably above typical), and 99213 ranks in the 95th percentile as well. These high percentiles for E/M and OCT imaging indicate a higher‑than‑typical throughput of established patient visits and diagnostic monitoring relative to national peers.

Use of compounded and newer intravitreal agents is material but mixed in competitiveness: J7999 (562 claims, $73 avg paid/claim, $41K revenue) is in the 90th percentile (typical, unremarkable volume) suggesting routine use of compounded therapies, while J2781 (270 claims, $120 avg paid/claim, $32.4K revenue) ranks in the 9th percentile indicating relatively low national volume for pegcetacoplan. This mix shows willingness to use a range of intravitreal pharmacotherapies but with varying market footprint by agent.

Several codes sit at low national percentiles for volume despite being billed (for example J2781 ranks in the 9th percentile, 92250 in the 10th percentile, and 92202 in the 9th percentile), which suggests the provider does not rely on those specific services as core revenue drivers. Conversely, mid‑to‑high percentiles for E/M and OCT suggest most procedural intensity is concentrated in injections plus monitoring rather than in ancillary imaging or specialized procedures.

The provider has long tenure in Medicare billing, with the NPI enumerated on 2006-02-02 (~20 years ago), which supports a sustained practice history and stable panel. Combined with the $1.6M Medicare lifetime revenue and concentrated code mix, this tenure implies an established retina practice that has persisted in a Medicare‑driven revenue model for roughly two decades.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

15 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,360	$690	$932.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	9,360	$30	$271.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,090	$100	$109.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	650	$90	$56.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,730	$30	$51.8K
J7999	Compounded drug, not otherwise classified	560	$70	$41K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	530	$70	$34.7K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	270	$120	$32.4K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	120	$90	$10.9K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	80	$110	$8.6K

Showing 1–10 of 15

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

John Hyatt — 3 of 15 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

15 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	17	60	840	$680	$623.7K
J2777	18	30	10,050	$30	$527.6K
J2781	11	10	690	$120	$102.6K
67028	25	70	580	$90	$72.3K
J7999	12	50	270	$70	$23.4K
92014	207	440	110	$80	$16K
92235	11	30	60	$100	$11.1K
99214	141	6,070	80	$70	$10.3K
92134	18	390	80	$30	$8.1K
92012	93	170	50	$60	$7.2K

Showing 1–10 of 15

Related Providers

Other providers that share a Tax Identification Number (TIN) with John Hyatt, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Francisco Folgar	SC	Ophthalmology Physician	$2.3M	$0
Christine Gonzales	OR	Ophthalmology Physician	$2.1M	$0
Lowrey King	SC	Ophthalmology Physician	$1.3M	$0
Kerry Solomon	SC	Ophthalmology Physician	$577.9K	$0
Robert Brame	SC	Ophthalmology Physician	$560.6K	$0
David Hunter	SC	Ophthalmology Physician	$549.8K	$0
Robert Reuther	SC	Ophthalmology Physician	$392.5K	$0
Jonathan Brugger	FL	Ophthalmology Physician	$373.3K	$0
Gene Howard	SC	Ophthalmology Physician	$362.5K	$0
Berdine Burger	SC	Ophthalmology Physician	$354.3K	$0

Nearby Providers

Other providers in the same ZIP code as John Hyatt, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Asante Ashland Community Hospital, LLC	OR	General Acute Care Hospital	$0	$9M
Southern Oregon Chiropractic-ashland LLC	OR	Rehabilitation Chiropractor	$0	$2.7M
Jeffrey Welder	OR	Ophthalmology Physician	$2.3M	$0
City Of Ashland	OR	Land Ambulance	$401.3K	$1.1M
David Dryland	OR	Rheumatology Physician	$1.4M	$0
Bear Creek Physical Therapy	OR	Physical Therapist	$0	$1.3M
Rogue Community Health	OR	Federally Qualified Health Center (FQHC)	$0	$1.3M
Ashland Surgery Center	OR	Ambulatory Surgical Clinic/Center	$1.2M	$3.2K
Robert Medeck	OR	Chiropractor	$8.2K	$1M
Jared Fredrickson	OR	Ophthalmology Physician	$650.8K	$0

John Hyatt — Billing Profile & Reimbursement Data

Sign up for John Hyatt — Billing Profile & Reimbursement Data policy alerts

John Hyatt — Billing Profile & Reimbursement Data

Sign up for John Hyatt — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References